-

Wolters Kluwer Chief Medical Officer Explores GenAI & Burnout at HIMSS AI in Healthcare Forum

CMO Dr. Peter Bonis will examine the issue of trust in workforce AI adoption

WALTHAM, Mass.--(BUSINESS WIRE)--Dr. Peter Bonis, Chief Medical Officer for Wolters Kluwer Health, will speak on artificial intelligence (AI) at the HIMSS AI in Healthcare Forum. The panel, titled “How Do We Support our Workforce to Trust and Adopt AI?” will be held on Thursday, September 5 from 1:15-2:05 PM in Boston.

“Successful adoption of AI in the healthcare setting requires demonstration of value, safety, and effectiveness,” said Dr. Bonis. “Trust must be earned. For example, an April 2024 Wolters Kluwer survey found nine out of 10 physicians have concerns about the source of GenAI content used for clinical decision support and they want transparency. I look forward to discussing the progress and barriers on adoption of AI technologies in the clinical setting.”

Joining Dr. Bonis on the panel are Dr. Patrick Thomas, Director of Digital Innovation, Pediatric Surgery, The University of Nebraska Medical Center-College of Medicine; Dr. Sonya Makhni, Medical Director, Mayo Clinic Platform; and Dr. Antoine Keller, Cardiothoracic Surgeon at Ochsner Lafayette General Hospital.

The panel will address the importance of ensuring a healthcare organization’s workforce is prepared and willing to effectively leverage AI in their clinical workflows. During the panel, AI clinician-experts will dive into the skills needed to build readiness for successful workforce adoption and trust in AI.

Building on Wolters Kluwer’s solid AI foundation

Wolters Kluwer Health is already working with healthcare systems to explore integrating GenAI into UpToDate through its experimental AI Labs. The company is committed to setting a standard for the responsible application of generative AI to the complex realities of front-line healthcare. A recent Wolters Kluwer Health survey, “Generative AI in Healthcare: Growing Physician Enthusiasm,” found 4 out of 5 of physicians (81%) say GenAI can improve care team interactions with patients.

Wolters Kluwer AI products, services, and expert solutions are based on a foundation of trust, transparency, and responsibility—in line with the company’s values. Wolters Kluwer’s AI Principles, which guide the design, development and deployment of advanced technologies in helping customers solve their most complex problems, can be found here.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

Contacts

Media
Suzanne Moran
Associate Director, External Communications
Wolters Kluwer Health
+1 (781) 255-5843
suzanne.moran@wolterskluwer.com

Wolters Kluwer

AEX:WKL

Release Versions

Contacts

Media
Suzanne Moran
Associate Director, External Communications
Wolters Kluwer Health
+1 (781) 255-5843
suzanne.moran@wolterskluwer.com

More News From Wolters Kluwer

Wolters Kluwer Releases Validation Framework for Evaluating Clinical AI at Point of Care

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today released its approach to validating and evaluating clinical AI that is designed to reflect how clinicians use and rely on AI at the point of care. Designed to help support governance committees, this framework moves beyond basic output evaluation to assess whether AI-generated outputs are clinically useful, grounded in trusted knowledge, and reliable to use in complex, real-world point of care scenarios. How can hospital governance co...

Wolters Kluwer Medi-Span Selected to Provide Personalized Medication Decision Support at The Christie NHS Foundation Trust

WALTHAM, Mass. & COPENHAGEN--(BUSINESS WIRE)--Wolters Kluwer Health has implemented its industry-leading medication decision support (MDS) solution, Medi-Span®, at the world-renowned specialist oncology center, The Christie NHS Foundation Trust. “The Christie is recognized globally for its excellence and commitment to delivering exceptional patient care,” says Israel Armstrong, Vice President for Medi-Span International at Wolters Kluwer Health. “We’re proud that our first Medi-Span implementat...

Wolters Kluwer partners with Microsoft to bring trusted clinical intelligence to Microsoft productivity workflows

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced a collaboration with Microsoft that integrates UpToDate®, a leading clinical decision support (CDS) solution, with Microsoft Dragon Copilot, Microsoft 365 Copilot, and Microsoft Teams. This will enable clinicians and care teams to access trusted, evidence‑based clinical intelligence directly within their documentation, communication, and collaboration workflows. Gold-standard clinical content for GenAI agents “This collabora...
Back to Newsroom